Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome

References

• Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52(19), 1527–1539 (2008).
   PubMed Web of Science ®Google Scholar
• Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit. Care Med. 34(7), 1913–1917 (2006).
   PubMed Web of Science ®Google Scholar
• Cruz DN, Bolgan I, Perazella MA et al.; North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI) Investigators. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE criteria. Clin. J. Am. Soc. Nephrol. 2(3), 418–425 (2007).
   PubMedGoogle Scholar
• Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J. Card. Fail. 16(1), 49–54 (2010).
   PubMed Web of Science ®Google Scholar
• Mehta RL, Kellum JA, Shah SV et al.; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11(2), R31 (2007).
   PubMed Web of Science ®Google Scholar
• Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16(11), 3365–3370 (2005).
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committe. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol. Dial. Transplant. 23(5), 1569–1574 (2008).
   PubMed Web of Science ®Google Scholar
• Taub PR, Gabbai-Saldate P, Maisel A. Biomarkers of heart failure. Congest. Heart Fail. 16(Suppl. 1), S19–S24 (2010).
   Google Scholar
• Uttenthal O. NGAL: a marker molecule for the distressed kidney? Clin. Lab. Int. 29, 39–41 (2005).
   Google Scholar
• Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 63(5), 1714–1724 (2003).
   PubMed Web of Science ®Google Scholar
• Kieran NE, Doran PP, Connolly SB et al. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 64(2), 480–492 (2003).
   PubMedGoogle Scholar
• Yuen PS, Jo SK, Holly MK, Hu X, Star RA. Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol. Genomics 25(3), 375–386 (2006).
   PubMed Web of Science ®Google Scholar
• Bolignano D, Basile G, Parisi P, Coppolino G, Nicocia G, Buemi M. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res. 12(1), 7–14 (2009).
   PubMed Web of Science ®Google Scholar
• Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A; NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54(6), 1012–1024 (2009).
   PubMed Web of Science ®Google Scholar
• Haase M, Devarajan P, Haase-Fielitz A et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J. Am. Coll. Cardiol. 57(17), 1752–1761 (2011).
   PubMed Web of Science ®Google Scholar
• Yndestad A, Landrø L, Ueland T et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur. Heart J. 30(10), 1229–1236 (2009).
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 40(2), 221–226 (2002).
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S, Marggraf G, Hüsing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 66(3), 1115–1122 (2004).
   PubMed Web of Science ®Google Scholar
• Lassus J, Harjola VP. Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail. Rev. 17(2), 251–261 (2012).
   Google Scholar
• Lassus J, Harjola VP, Sund R et al.; for the FINN-AKVA Study group. Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur. Heart J. 28(15), 1841–1847 (2007).
   PubMed Web of Science ®Google Scholar
• Lassus JP, Nieminen MS, Peuhkurinen K et al.; FINN-AKVA study group. Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur. Heart J. 31(22), 2791–2798 (2010).
   PubMed Web of Science ®Google Scholar
• Eriksen BO, Mathisen UD, Melsom T et al. Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int. 78(12), 1305–1311 (2010).
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 290(2), F517–F529 (2006).
   PubMed Web of Science ®Google Scholar
• Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62(1), 237–244 (2002).
   PubMed Web of Science ®Google Scholar
• Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 73(7), 863–869 (2008).
   PubMed Web of Science ®Google Scholar
• Liangos O, Tighiouart H, Perianayagam MC et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 14(6), 423–431 (2009).
   PubMed Web of Science ®Google Scholar
• Damman K, Ng Kam Chuen MJ, MacFadyen RJ et al. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J. Am. Coll. Cardiol. 57(22), 2233–2241 (2011).
   PubMed Web of Science ®Google Scholar
• Tschoeke SK, Oberholzer A, Moldawer LL. Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit. Care Med. 34(4), 1225–1233 (2006).
   PubMedGoogle Scholar
• Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J. Clin. Invest. 110(8), 1083–1091 (2002).
   PubMed Web of Science ®Google Scholar
• Melnikov VY, Ecder T, Fantuzzi G et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J. Clin. Invest. 107(9), 1145–1152 (2001).
   PubMed Web of Science ®Google Scholar
• Miaolin C, Bo X, Song X et al. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery. Nephron Clin. Prac. 115, 66–72 (2010).
   Google Scholar
• Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 70(1), 199–203 (2006).
   PubMed Web of Science ®Google Scholar
• Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 73(9), 1008–1016 (2008).
   PubMed Web of Science ®Google Scholar
• Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol. 16(10), 3046–3052 (2005).
   PubMed Web of Science ®Google Scholar
• Daniels LB, Maisel AS. Natriuretic peptides. J. Am. Coll. Cardiol. 50(25), 2357–2368 (2007).
   PubMedGoogle Scholar
• de Cal M, Haapio M, Cruz DN et al. B-type natriuretic peptide in the critically ill with acute kidney injury. Int. J. Nephrol. 2011, 951629 (2011).
   Google Scholar
• Maisel AS, Katz N, Hillege HL et al.; Acute Dialysis Quality Initiative Consensus Group. Biomarkers in kidney and heart disease. Nephrol. Dial. Transplant. 26(1), 62–74 (2011).
   Google Scholar
• Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 60(5), 1645–1657 (2001).
   PubMed Web of Science ®Google Scholar
• Lorenzen JM, Hafer C, Faulhaber-Walter R et al. Osteopontin predicts survival in critically ill patients with acute kidney injury. Nephrol. Dial. Transplant. 26(2), 531–537 (2011).
   PubMed Web of Science ®Google Scholar
• Damman K, Masson S, Hillege HL et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur. Heart J. 32(21), 2705–2712 (2011).
   PubMed Web of Science ®Google Scholar
• Tögel F, Isaac J, Hu Z, Weiss K, Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 67(5), 1772–1784 (2005).
   PubMed Web of Science ®Google Scholar
• Van Balkom BWM, Pisitjun T, Verhaar MC, Knepper MA. Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int. 80, 1138–1145 (2011).
   Google Scholar
• Knepper MA, Pisitkun T. Exosomes in urine: who would have thought? Kidney Int. 72(9), 1043–1045 (2007).
   PubMed Web of Science ®Google Scholar
• Zhou H, Cheruvanky A, Hu X et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 74(5), 613–621 (2008).
   PubMed Web of Science ®Google Scholar
• Hata N, Yokoyama S, Shinada T et al. Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population. Eur. J. Heart Fail. 12(1), 32–37 (2010).
   PubMed Web of Science ®Google Scholar
• Maisel AS, Mueller C, Fitzgerald R et al. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur. J. Heart Fail. 13(8), 846–851 (2011).
   PubMed Web of Science ®Google Scholar
• Damman K, Van Veldhuisen DJ, Navis G et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96(16), 1297–1302 (2010).
   PubMed Web of Science ®Google Scholar
• Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J. Am. Coll. Cardiol. 55(19), 2024–2033 (2010).
   PubMed Web of Science ®Google Scholar
• Bellomo R, Auriemma S, Fabbri A et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int. J. Artif. Organs 31(2), 166–178 (2008).
   PubMed Web of Science ®Google Scholar
• Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J. Extra. Corpor. Technol. 40(4), 257–267 (2008).
   PubMedGoogle Scholar
• Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ et al. Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int. 77(10), 913–920 (2010).
   Google Scholar
• Ho J, Lucy M, Krokhin O et al. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case–control study. Am. J. Kidney Dis. 53(4), 584–595 (2009).
   PubMed Web of Science ®Google Scholar
• Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106(5), 1864–1866 (2005).
   PubMed Web of Science ®Google Scholar
• Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR. Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin. Chem. 33(6), 775–779 (1987).
   PubMed Web of Science ®Google Scholar
• Hofstra JM, Deegens JK, Steenbergen EJ, Wetzels JF. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy. Nephrol. Dial. Transplant. 23(10), 3160–3165 (2008).
   Google Scholar
• Portilla D, Dent C, Sugaya T et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 73(4), 465–472 (2008).
   PubMed Web of Science ®Google Scholar
• Negishi K, Noiri E, Doi K et al. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am. J. Pathol. 174(4), 1154–1159 (2009).
   PubMed Web of Science ®Google Scholar
• Ronco C, McCullough P, Anker SD. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur. Heart J. 31(6), 703–711 (2010).
   PubMed Web of Science ®Google Scholar
• Murray PT, Devarajan P, Levey AS et al. A framework and key research questions in AKI diagnosis and staging in different environments. Clin. J. Am. Soc. Nephrol. 3(3), 864–868 (2008).
   Web of Science ®Google Scholar
• Ahlström A, Tallgren M, Peltonen S, Pettilä V. Evolution and predictive power of serum cystatin C in acute renal failure. Clin. Nephrol. 62(5), 344–350 (2004).
   PubMed Web of Science ®Google Scholar
• McIlroy DR, Wagener G, Lee HT. Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 112(4), 998–1004 (2010).
   Google Scholar
• Maisel AS, Krishnaswamy P, Nowak RM et al.; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347(3), 161–167 (2002).
   PubMed Web of Science ®Google Scholar